CEFTRIAXONE INJECTION, USP
BAXTER CORPORATION
Quick answers
Is there a shortage of CEFTRIAXONE INJECTION, USP in Canada?
No. There is no current shortage of CEFTRIAXONE INJECTION, USP 2000MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ROCEPHIN PWS INJ 0.25GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN INJ 10GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN PWS INJ 1GM/VIAL
HOFFMANN-LA ROCHE LIMITED
CEFTRIAXONE SODIUM FOR INJECTION BP
SANDOZ CANADA INCORPORATED
ROCEPHIN PWS 2GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN PWS 1GM/VIAL
HOFFMANN-LA ROCHE LIMITED
DIN
02499738
Strength
2000MG
Dosage Form
Solution
Route
Intravenous
Active Ingredient
CEFTRIAXONE (CEFTRIAXONE SODIUM)
See all CEFTRIAXONE (CEFTRIAXONE SODIUM) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BAXTER CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 00438014
DIN 00786292
DIN 00438049
DIN 00786209
DIN 00437999
DIN 00786217
DIN 00438030
DIN 00438022
DIN 00438006
DIN 00828602
900MG · DIN 00060208
900MG · DIN 00786160